The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Epitomics Receives Notice of Allowance from the USPTO

02-Nov-2011 | Source : | Visits : 7533
BURLINGAME, CA - Epitomics Inc., a California based biotech company, announced today in a press release that it has received a Notice of Allowance from the United States Patent and Trademark Office for its Method for Identifying Differentially Expressed Proteins (application 10/705,109).

The Notice allowed 17 claims for detection of differentially expressed proteins in cell samples using libraries of antibodies. This method has several potentially broad applications in the research and drug discovery markets, especially in the field of cancer.

“We are very excited to be granted the claims of this novel method,” stated Dr. Guo-Liang Yu, Chief Executive Officer. “This is another step towards building a world class intellectual property estate around our unique and proprietary rabbit monoclonal technology. We look forward to continued success in the development of our technology and patents, and ultimately to providing the best antibodies and solutions to researchers and clinicians.”

Epitomics Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications.


Related Articles